During the course of these studies we reported LPAR1 and LPAR3 expression was increased in a subset of human HCC and cirrhotic non-tumor liver (NTL) compared to liver from non-tumor burdened patients [27]. This evidence concerns the gene LPAR1 and hepatocellular carcinoma.